News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results and Recent Developments
May 10, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its financial results for the first quarter, cash balance as of March 31, 2011 and recent developments.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
July 22, 2026
·
1 min read
·
Jef Akst
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Sickle cell disease
Agios axes next-gen sickle cell candidate after it fails to best Novo’s asset
July 21, 2026
·
2 min read
·
Gabrielle Masson
Earnings
Novartis stays ‘geography-agnostic’ in dealmaking amid flurry of China deals
July 21, 2026
·
2 min read
·
Tristan Manalac
